Home › Enlarged Prostate (BPH) › NCT07680543
ProVIDE Studies Post Exit Analysis
RecruitingObservational study
Who can join
Ages 45 and older · Men
Full eligibility criteria
Inclusion Criteria: * 1\. US based subjects previously enrolled in the ProVIDE Study or the ProVIDE II Bridging Study who had a ProVee device removed. * 2\. Subjects who withdrew consent or were withdrawn by site Study PI. * 3\. Subjects consented to make data available. Exclusion Criteria: * 1\. Incomplete records available. * 2\. Subjects who exited the studies due to restarting BPH medication while they were enrolled. * 3\. Subjects who did not receive a ProVee in the ProVIDE Study or the ProVIDE II Bridging Study. * 4\. Subjects who exited the studies due to prostate cancer.
About the study
A study to collect data on the post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.
What is being tested
- ProVee Urethral Expander System (device)
Sponsor: ProVerum Medical · Participants: 25 · Started: Sep 30, 2026
Contact the study team
- Diane Gargus · Phone: 1-720-472-1504
Official record on ClinicalTrials.gov — NCT07680543
Locations in the U.S.
| Illinois | Comprehensive Urologic Care, Lake Barrington |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.